Cargando…
SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
Huntington's disease (HD) is a devastating neurodegenerative disorder for which there are no disease-modifying treatments. The molecular pathogenesis of HD is complex and many mechanisms and cellular processes have been proposed as potential sites of therapeutic intervention. However, prior to...
Autores principales: | Bobrowska, Anna, Donmez, Gizem, Weiss, Andreas, Guarente, Leonard, Bates, Gillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325254/ https://www.ncbi.nlm.nih.gov/pubmed/22511966 http://dx.doi.org/10.1371/journal.pone.0034805 |
Ejemplares similares
-
Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes In Vivo
por: Bobrowska, Anna, et al.
Publicado: (2021) -
Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
por: Bobrowska, Anna, et al.
Publicado: (2011) -
SIRT1 and SIRT2: emerging targets in neurodegeneration
por: Donmez, Gizem, et al.
Publicado: (2013) -
The Effects of SIRT1 on Alzheimer's Disease Models
por: Donmez, Gizem
Publicado: (2012) -
Urea cycle regulation by mitochondrial sirtuin, SIRT5
por: Nakagawa, Takashi, et al.
Publicado: (2009)